Fine Foods & Pharmaceuticals N.T.M. S.p.A.

DB:9S5 Stock Report

Market Cap: €205.7m

Fine Foods & Pharmaceuticals N.T.M Balance Sheet Health

Financial Health criteria checks 5/6

Fine Foods & Pharmaceuticals N.T.M has a total shareholder equity of €128.4M and total debt of €60.6M, which brings its debt-to-equity ratio to 47.2%. Its total assets and total liabilities are €239.8M and €111.4M respectively. Fine Foods & Pharmaceuticals N.T.M's EBIT is €13.9M making its interest coverage ratio 3.3. It has cash and short-term investments of €15.2M.

Key information

47.2%

Debt to equity ratio

€60.64m

Debt

Interest coverage ratio3.3x
Cash€15.21m
Equity€128.40m
Total liabilities€111.41m
Total assets€239.81m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 9S5's short term assets (€106.4M) exceed its short term liabilities (€67.6M).

Long Term Liabilities: 9S5's short term assets (€106.4M) exceed its long term liabilities (€43.8M).


Debt to Equity History and Analysis

Debt Level: 9S5's net debt to equity ratio (35.4%) is considered satisfactory.

Reducing Debt: 9S5's debt to equity ratio has increased from 21.4% to 47.2% over the past 5 years.

Debt Coverage: 9S5's debt is well covered by operating cash flow (65.8%).

Interest Coverage: 9S5's interest payments on its debt are well covered by EBIT (3.3x coverage).


Balance Sheet


Discover healthy companies